1. Home
  2. CDLR vs BEAM Comparison

CDLR vs BEAM Comparison

Compare CDLR & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDLR
  • BEAM
  • Stock Information
  • Founded
  • CDLR 2008
  • BEAM 2017
  • Country
  • CDLR Denmark
  • BEAM United States
  • Employees
  • CDLR N/A
  • BEAM N/A
  • Industry
  • CDLR
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CDLR
  • BEAM Health Care
  • Exchange
  • CDLR Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • CDLR 1.9B
  • BEAM 1.7B
  • IPO Year
  • CDLR N/A
  • BEAM 2020
  • Fundamental
  • Price
  • CDLR $22.57
  • BEAM $16.64
  • Analyst Decision
  • CDLR
  • BEAM Strong Buy
  • Analyst Count
  • CDLR 0
  • BEAM 10
  • Target Price
  • CDLR N/A
  • BEAM $48.56
  • AVG Volume (30 Days)
  • CDLR 37.8K
  • BEAM 2.5M
  • Earning Date
  • CDLR 08-26-2025
  • BEAM 08-05-2025
  • Dividend Yield
  • CDLR N/A
  • BEAM N/A
  • EPS Growth
  • CDLR N/A
  • BEAM N/A
  • EPS
  • CDLR 0.31
  • BEAM N/A
  • Revenue
  • CDLR $319,011,025.00
  • BEAM $60,272,000.00
  • Revenue This Year
  • CDLR $116.02
  • BEAM N/A
  • Revenue Next Year
  • CDLR $80.90
  • BEAM $17.18
  • P/E Ratio
  • CDLR $20.73
  • BEAM N/A
  • Revenue Growth
  • CDLR 171.33
  • BEAM N/A
  • 52 Week Low
  • CDLR $17.37
  • BEAM $13.53
  • 52 Week High
  • CDLR $28.75
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • CDLR 65.19
  • BEAM 38.79
  • Support Level
  • CDLR $21.02
  • BEAM $15.60
  • Resistance Level
  • CDLR $21.61
  • BEAM $18.17
  • Average True Range (ATR)
  • CDLR 0.37
  • BEAM 0.93
  • MACD
  • CDLR 0.16
  • BEAM -0.20
  • Stochastic Oscillator
  • CDLR 100.00
  • BEAM 29.89

About CDLR Cadeler AS

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning and provides marine and engineering operations to the wind industry, focusing on safety and the environment. The company operates six offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: